Merus N.V. P/S 2011-2026 | MRUS

P/S Jährlich Merus N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
82.5	57.1	20.4	19.4	26.9 K	13.1	7.67	24.3	234	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
26.9 K	7.67	3.04 K

P/S anderer Aktien in der Pharmaeinzelhändler

Name	P/S	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.75	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	1.73	$ 21.94	2.48 %	$ 1.03 B	USA
I-Mab IMAB	94.1	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	489	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	137	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.53	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	105	$ 0.9	0.49 %	$ 6.62 M	China
Genfit SA GNFT	1.96 K	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	3.33	$ 22.66	3.19 %	$ 3.76 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.39 K	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	144	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	0.935	-	1.93 %	$ 17.4 M	USA
Ampio Pharmaceuticals AMPE	106	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	2.61	-	-	-	Russia
Aeterna Zentaris AEZS	7.87	-	5.93 %	$ 314 M	Canada
Applied Therapeutics APLT	54.1	-	-	$ 8.42 M	USA
Aptinyx APTX	204	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	0.099	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	6.61	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	1.34	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	35.7	$ 102.75	-2.57 %	$ 27.2 B	Germany
Applied Genetic Technologies Corporation AGTC	65.5	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	10.5	$ 4.14	1.35 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	9.15	$ 23.58	1.38 %	$ 3 B	USA
Ayala Pharmaceuticals AYLA	11.2	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	4.27	$ 1.44	-0.35 %	$ 383 M	Britain
AstraZeneca PLC AZN	2.17	-	-	$ 96.9 B	Britain
Can-Fite BioPharma Ltd. CANF	759	$ 2.92	-0.45 %	$ 4.81 M	Israel
BioDelivery Sciences International BDSI	1.85	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	66.4	-	0.49 %	$ 251 B	Cayman-islands
CureVac N.V. CVAC	281	-	-	$ 867 M	Germany
bluebird bio BLUE	2.27	-	-	$ 546 M	USA
Cardiff Oncology CRDF	196	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	24	$ 1.1	3.77 %	$ 13.4 M	USA
Cabaletta Bio CABA	50.3 M	$ 2.99	1.19 %	$ 300 M	USA
Cara Therapeutics CARA	2.58	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	36.1	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	110	-	-	$ 3.45 B	USA